LT
ABBV icon

Legacy Trust’s AbbVie ABBV Stock Holding History

Legacy Trust’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.78M Buy
8,177
+814
+11% +$181K 0.34% 60
2025
Q4 		$1.68M Buy
7,363
+321
+5% +$73.1K 0.31% 62
2025
Q3 		$1.63M Buy
7,042
+4,583
+186% +$933K 0.32% 63
2025
Q2 		$456K Sell
2,459
-52
-2% -$9.66K 0.11% 107
2025
Q1 		$526K Sell
2,511
-360
-13% -$70K 0.13% 103
2024
Q4 		$510K Sell
2,871
-51
-2% -$9.38K 0.12% 103
2024
Q3 		$577K Buy
2,922
+370
+14% +$69.1K 0.13% 103
2024
Q2 		$438K Sell
2,552
-101
-4% -$16.7K 0.11% 107
2024
Q1 		$483K Sell
2,653
-668
-20% -$115K 0.12% 107
2023
Q4 		$515K Sell
3,321
-119
-3% -$17.3K 0.13% 103
2023
Q3 		$513K Buy
3,440
+16
+0.5% +$2.35K 0.15% 97
2023
Q2 		$461K Sell
3,424
-150
-4% -$22K 0.13% 109
2023
Q1 		$570K Buy
3,574
+210
+6% +$32.1K 0.17% 93
2022
Q4 		$544K Buy
+3,364
New +$516K 0.17% 92

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Legacy Trust's ABBV Position: Q1 2026 in Review

Legacy Trust increased its AbbVie (ABBV) stake by 11% in Q1 2026, buying an estimated $181K and bringing the position to 8,177 shares worth $1.78M. The position accounts for 0.34% of the portfolio, ranked #60.

Legacy Trust first reported a position in ABBV in Q4 2022 and has held it in 14 quarters since. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Legacy Trust held 8,177 shares of AbbVie worth $1.78M as of Q1 2026.
  • Legacy Trust bought 814 AbbVie shares in Q1 2026, an estimated $181K.
  • AbbVie made up 0.34% of Legacy Trust's portfolio in Q1 2026, its #60 holding.
  • Legacy Trust first reported a position in AbbVie in Q4 2022 and has held it in 14 quarters since.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Legacy Trust's 13F filing for Q1 2026, filed 14 Apr 2026.